ETR:HNL Dr. Hönle (HNL) Stock Price, News & Analysis €7.66 -0.32 (-4.01%) As of 01/21/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlines About Dr. Hönle Stock (ETR:HNL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Hönle alerts:Sign Up Key Stats Today's Range€7.56▼€7.8650-Day Range€6.68▼€9.0052-Week Range€11.00▼€20.30Volume14,913 shsAverage VolumeN/AMarket Capitalization$46.42 millionP/E RatioN/ADividend Yield2.61%Price TargetN/AConsensus RatingN/A Company OverviewDr. Hönle AG engages in the supply of industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, automotive, optics and opto-electronics, medical technology, and glass processing. The Equipment & Systems segment engages in the provision of solutions used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.Read More… Receive HNL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Hönle and its competitors with MarketBeat's FREE daily newsletter. Email Address HNL Stock News HeadlinesDr. Hönle AG Announces Change in Voting RightsJanuary 3, 2025 | msn.comBest Hotels in Honolulu - Oahu, HI for 2024October 25, 2024 | travel.usnews.comDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.January 22, 2025 | Weiss Ratings (Ad)DRHNF Dr. Hönle AGOctober 19, 2024 | seekingalpha.comThe past five years for Dr. Hönle (ETR:HNL) investors has not been profitableOctober 14, 2024 | finance.yahoo.comHNL Lab Medicine Announces Relocation of Allentown - AMC 17th Street Patient Service CenterOctober 4, 2024 | markets.businessinsider.comHNL Lab Medicine Relocates Route 61 Patient Service Center to Brunswick Business CenterSeptember 24, 2024 | markets.businessinsider.comTravel nurse fired amid Oahu nurse strike, lockoutSeptember 14, 2024 | msn.comSee More Headlines HNL Stock Analysis - Frequently Asked Questions How have HNL shares performed this year? Dr. Hönle's stock was trading at €7.56 on January 1st, 2025. Since then, HNL stock has increased by 1.3% and is now trading at €7.66. View the best growth stocks for 2025 here. What other stocks do shareholders of Dr. Hönle own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Hönle investors own include D.R. Horton (DHI), Dr Pepper Snapple Group (DPS), Meta Platforms (META), MARA (MARA), Grayscale Future of Finance ETF (GFOF), BNY Mellon Strategic Municipal Bond Fund (DSM) and Dr. Ing. h.c. F. Porsche (DRPRF). Industry, Sector and Symbol Stock ExchangeETR SectorIndustrials Industry Electrical Equipment & Parts Sub-IndustryN/A Current SymbolETR:HNL CUSIPN/A CIKN/A Webwww.hoenle.de Phone49 89 85608 0FaxN/AEmployees581Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)(€0.91) Trailing P/E RatioN/A Forward P/E Ratio5.36 P/E Growth-0.39Net Income$-5,370,000.00 Net Margins-5.45% Pretax MarginN/A Return on Equity-5.51% Return on Assets4.56% Debt Debt-to-Equity Ratio59.06 Current Ratio1.98 Quick Ratio0.85 Sales & Book Value Annual Sales$98.69 million Price / Sales0.47 Cash Flow€0.39 per share Price / Cash Flow19.54 Book Value€15.43 per share Price / Book0.50Miscellaneous Outstanding Shares6,060,000Free FloatN/AMarket Cap$46.42 million OptionableNot Optionable Beta1.45 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report This page (ETR:HNL) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Hönle AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Hönle With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.